NEPHROS INC's ticker is NEPH and the CUSIP is 640671400. A total of 17 filers reported holding NEPHROS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16 | -5.9% | 11 | 0.0% | 0.00% | – |
| Q2 2023 | $17 | -93.3% | 11 | -95.4% | 0.00% | – |
| Q1 2023 | $254 | -97.9% | 237 | -97.7% | 0.00% | – |
| Q4 2022 | $12,216 | +11.1% | 10,531 | -11.3% | 0.00% | – |
| Q3 2022 | $11,000 | +1000.0% | 11,874 | +2157.4% | 0.00% | – |
| Q2 2022 | $1,000 | – | 526 | +4681.8% | 0.00% | – |
| Q1 2022 | $0 | – | 11 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 11 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 11 | -59.3% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 27 | -92.1% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 343 | +21.6% | 0.00% | – |
| Q4 2020 | $2,000 | – | 282 | +2463.6% | 0.00% | – |
| Q3 2020 | $0 | – | 11 | -47.6% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 21 | -95.7% | 0.00% | – |
| Q1 2020 | $3,000 | -50.0% | 492 | -18.3% | 0.00% | – |
| Q4 2019 | $6,000 | – | 602 | +2766.7% | 0.00% | – |
| Q3 2019 | $0 | – | 21 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parkman Healthcare Partners LLC | 199,724 | $1,987,000 | 0.57% |
| INGALLS & SNYDER LLC | 134,539 | $1,339,000 | 0.07% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 5,908 | $59,000 | 0.03% |
| B. Riley Wealth Advisors, Inc. | 14,254 | $142,000 | 0.01% |
| HighTower Advisors, LLC | 43,210 | $430,000 | 0.00% |
| BLAIR WILLIAM & CO/IL | 34,249 | $341,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 22,501 | $224,000 | 0.00% |
| DEUTSCHE BANK AG\ | 200 | $1,000 | 0.00% |
| BlackRock Inc. | 2,562 | $25,000 | 0.00% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 367 | $4,000 | 0.00% |